BioSpace News Archive

Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that it expects to sell, subject to market and other conditions, an aggregate of $100.0 million principal amount of its convertible senior notes due 2026, or the notes, in an underwritten public offering

VIVA Physicians, a not-for-profit organization dedicated to advancing the field of vascular medicine and intervention through education and research, announces the third round of 21 highly anticipated late-breaking clinical trial results at VIVA19 hosted at Wynn Las Vegas.

First-of-its-Kind Pivotal Study of the Tack Endovascular System® Demonstrates 100% Dissection Resolution in Challenging Below-the-Knee Disease

First multi-site randomized trial shows stellate ganglion block is effective in treating PTSD symptoms in active-duty service members

Data published in Science Translational Medicine with Emulate’s Liver-Chip demonstrate robust reproducibility and diverse phenotypes of human liver toxicities and species-specific drug responses

The American Association of Nurse Anesthetists commends the Centers for Medicare & Medicaid Services’ for recognizing a Certified Registered Nurse Anesthetist’s ability to perform pre-anesthetic assessments in Ambulatory Surgical Centers as part of the final rule made Nov. 1 on the Physician Fee Schedule..

Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effective treatments for oncological and non-oncological conditions, announces financial results for the three and nine months ended September 30, 2019.

GenMark Diagnostics, Inc. (Nasdaq: GNMK), a leading provider of automated, multiplex molecular diagnostic testing systems, today announced financial results for the quarter ended September 30, 2019.

Brings more than 20 years of experience in the life science industry to support pre-commercial and regulatory activities of Phase 3 candidate ALZT

OraSure Technologies, Inc., a leader in point-of-care diagnostic tests and specimen collection devices, announced its financial results for the three and nine months ended September 30, 2019.